Whole-genome sequencing has demonstrated that a mutation in mediator complex subunit 12 (MED12) is present in up to 70% of uterine fibroids and that there is an association between the rate of MED12 mutations and the tumor number [12,26]. Here, MED12 is linked to neoplasm.